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Objectives: Upon completion of this article, the reader will be
able to describe management of complications, and methods
to avoid them, in the thermal ablation treatment of liver and
kidney tumors.
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Image-guided tumor ablation with use of thermal energy
has been widely used for the treatment of liver and kidney
malignancies. The common techniques of ablation include
radiofrequency ablation (RFA), microwave ablation (MWA),
and cryoablation.1–14 RFA has been the most commonly used
and investigated technique in the treatment of liver malig-
nancies. The efficacy and safety of RFA have been reported in
the literature, and RFA has been considered as the first choice
of ablation therapy for liver malignancies.4,15,16 Recently,
MWA has received attention due to the potential of micro-
wave energy to produce faster heating over a larger volume of
tissue with less susceptibility to heat-sink effects.5,17–22
Cryoablation is less commonly used in the liver than RFA or
MWA because it requires placement of multiple cryoprobes
and does not allow tract ablation, raising concern for an
increased risk of bleeding. In addition, there are other risks
of serious complications such as cryoshock and parenchymal
crack when cryoablation is performed, especially in the
liver.18,19,23 In the treatment of small renal tumors, RFA
and cryoablation are the two most commonly used ablation
techniques, and each has the potential for renal parenchymal
preservation with lower morbidity compared with open
surgical tumor resection.7,9,11,24–26
Although image-guided thermal ablation has been accept-
ed as a promising nonsurgical treatment for liver and kidney
malignancies, the risks of the procedure must be considered
as part of the therapeutic decision-making process. Early
detection and proper management of complications are
essential, and knowledge about potential complications
may help the practitioner avoid significant injury to the
patient. Major complications are defined as events that lead
to substantial morbidity and disability, increasing the level of
care, or resulting in hospital admission or substantially
lengthened hospital stay. These include any cases in which
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Abstract Image-guided thermal ablation is a widely accepted tool in the treatment of a variety of
solid organ neoplasms. Among the different techniques of ablation, radiofrequency
ablation, cryoablation, and microwave ablation have been most commonly used and
investigated in the treatment of liver and kidney neoplasms. This article will review
complications following thermal ablation of tumors in the liver and kidney, and discuss
the risks and clinical presentation of each complication as well as how to treat and
potentially avoid complications.
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a blood transfusion or additional interventional procedure is
required. All other complications are considered minor. Sev-
eral complications can be classified as either amajor or minor
complications, depending on severity. Side effects are ex-
pected undesired consequences of the procedure that, al-
though occurring frequently, rarely result in substantial
patient morbidity. These include pain, postablation syn-
drome, asymptomatic pleural effusion, and minimal asymp-
tomatic perihepatic (or perirenal) fluid or blood collections.14
This review will discuss the complications and side effects of
thermal ablation in the treatment of liver and kidney
malignancies.
Liver
The liver has been the most studied target organ for thermal
ablation of both primary and metastatic malignancies. There
have been substantially more data in terms of the complica-
tions that occur with liver ablation than in any other site.
Overall, the rates of major complications and mortality are
low with thermal ablation of liver malignancies, with mor-
tality reported in 0 to 1.4% of cases andmajor complications in
2.2 to 5.7% of cases.1,15,27–40 In contrast, the mortality and
major complication rates of MWA have been reported as 0 to
0.4% and 2.6 to 4.6%, respectively.1,15,32,34,39 In recent studies,
the types and incidences of complications caused by RFA and
MWA of liver malignancies are similar and comparable in the
clinical setting.15,34 Causes of death have included intestinal
perforation, portal vein thrombosis, liver failure, septic shock,
and massive hepatic hemorrhage.29,31,37,38 Major complica-
tions include hemorrhage, liver failure, injuries to bowel and
biliary tree, infections such as abscesses and peritonitis,
vascular thrombosis and hepatic infarction, pleural compli-
cations (pneumothorax, hemothorax, large effusion requiring
drainage), biliary strictures, bilomas, cholecystitis, broncho-
biliary fistulas, arteriovenous fistula leading to rapid tumor
dissemination, skin burns, and tumor seeding.1,15,27–41 These
complications are discussed below.
Vascular Complications
Hemorrhage is one of the most commonmajor complications
encountered with hepatic thermal ablation. Overall, the risk
of significant bleeding is low (< 2%), but it is influenced by the
status of the underlying hepatic parenchyma and the tumor
location.29 Coagulopathy in cirrhotic patients is the most
important risk factor for bleeding. Other risk factors include
the location of the tumor adjacent to amajor blood vessel, and
the use of multiple punctures or multiple needles (RFA
electrodes or MWA antennas).30,40 Bleeding is generally
intraperitoneal, but it can be subcapsular, intralesional, or
into the pleural space. Most venous bleeding tends to be self-
limited and can be managed conservatively; blood transfu-
sion, transarterial embolization, or surgery may be necessary
in cases of arterial bleeding.29,30
To prevent significant hemorrhage, any significant coagul-
opathy must be corrected before and after the procedure. In
addition, the practitioner should try to minimize the number
of transgressions of the liver capsule, and every effort should
be made during needle placement to avoid traversing major
vessels and by traversing at least some normal hepatic
parenchyma. With both RFA and MWA, cauterization of the
needle tract after ablation can be performed to reduce the risk
of hemorrhage.30 One other technique has been described for
patients whomay be at increased risk for hemorrhage. Takaki
et al reported using a combination of arterial embolization
before RFA that increased the size of ablation zone by reduc-
ing arterial blood supply and significantly decreasing the
incidence of major hemorrhage.31
Aside from hemorrhage, other potential vascular compli-
cations include portal venous thrombosis (►Fig. 1), hepatic
venous thrombosis, hepatic infarction, arteriovenous fistula,
and hepatic artery pseudoaneurysm.28–30,37,38,40,42,43 The
reported incidences of portal venous thrombosis and hepatic
venous thrombosis are 1.7 and 1.4%, respectively.29,38 Portal
vein thrombosis normally will manifest soon after the proce-
dure. Smaller caliber vessels (< 3 mm) tend to be more prone
to thrombosis from thermal injury due to the absence of a
vascular perfusion-mediated heat-sink effect that is largely
dependent on the size of the vessel. Thermal damage may
cause thrombosis even in relatively large vessels if the blood
flow is decreased, such as during the Pringle maneuver
(clamping of porta hepatis to interrupt hepatic arterial and
portal venous flow to the liver).40,44–46 Ding et al reported a
case of percutaneous MWA in a patient with portal venous
thrombosis.15 In this case, the ablated tumor was in close
proximity to the portal vein, and because of underlying
cirrhosis, there was reduced portal flow.When vessel throm-
bosis does occur following percutaneous ablation, treatment
is tailored to the individual circumstance. Often, thrombi
within portal and hepatic veins will require no specific
therapy, but systemic anticoagulation or local thrombolysis
may be necessary if liver function is affected.28,40
Hepatic infarction is an uncommon complication of ther-
mal ablation, likely because of the dual blood supply to the
liver as well as the liver’s ability to develop extensive collat-
eral pathways.29,37,40,47 A large case review conducted to
specifically evaluate the frequency of hepatic infarction fol-
lowing RFA demonstrated hepatic infarction in 20 of 1,120
sessions (1.8%).47 Most of these patients were managed
conservatively, and the infarcted tissue resolved. However,
there were accompanied complications in six cases including
biloma (n ¼ 2), abscess (n ¼ 2), portal vein thrombosis
(n ¼ 1), and death from hepatic failure related to lobar
infarction (n ¼ 1).
Biliary Complications
Complications of bile leakage and biloma formation following
thermal injury to the biliary tree typically occur in patients
with lesions located adjacent to the bile duct (►Fig. 2).15,30
Major bile ducts near the hepatic hilum are generally consid-
ered to be protected from thermal damage by the heat-sink
effect of the portal vein. However, if the blood flow in the
portal vein is reduced because of the Pringle maneuver,
cirrhosis, or portal vein thrombosis, the risk of bile duct
injury increases. Thermal ablation of lesions near the hepatic
hilum is challenging because the complete ablation of the
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Figure 2 (A) Axial arterial phase MR image demonstrates an early
enhancing lesion in segment VIII (arrow) that also showed washout on
delayed imaging (not shown), compatible with hepatocellular carcinoma.
(B) Coronal noncontrast-enhanced reformatted CT image during micro-
wave ablation demonstrates an ablation antenna (arrowheads) adjacent to
a localizer coil (arrow) that was placed during contrast administration.
(C) Coronal thick slab MRCP image acquired 4 months postablation
demonstrates dilated intrahepatic ducts (arrowheads) with a normal
common bile duct (thin arrow). There is also heterogeneous necrosis and
cystic change in the ablation site (thick arrow). (D) Image during a
percutaneous transhepatic cholangiogram from a left-sided approach
demonstrates a dilated left biliary tree (arrowheads) that leads to a stenosis
near the confluence of the left and right hepatic ducts (large arrow). A
plastic biliary stent is present in the common bile duct (small arrows). CT,
computed tomography; MR, magnetic resonance; MRCP, magnetic reso-
nance cholangiopancreatography.
Figure 1 (A) Axial arterial phase postcontrast T1 MR image of the
abdomen demonstrates a segment VIII early enhancing lesion (large
arrow) adjacent to a branch of the right portal vein (arrowhead). This
arises within a site of previously ablated hepatocellular carcinoma
(small arrows). (B) Coronal delayed phase postcontrast T1 MR image of
the abdomen demonstrates washout and late capsular enhancement
of the segment VIII lesion (large arrow), adjacent to the right portal
vein (arrowhead). The previously ablated hepatocellular carcinoma is
again noted laterally (thin arrows). (C) Axial postcontrast CT image
performed during microwave ablation demonstrates the ablation
antenna (arrowheads) adjacent to the right portal vein (arrow). (D)
Coronal delayed postcontrast T1 MR image of the abdomen acquired
1 month after ablation demonstrates hypoenhancement of the abla-
tion site (arrows) with expansile, nonenhancing acute thrombus within
the portal venous system (arrowheads). CT, computed tomography;
MR, magnetic resonance.
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tumor and the protection of major bile ducts or portal venous
branches are frequently incompatible goals.15,30,40 If neces-
sary, it is possible to treat lesions adjacent to large bile ducts.
In this situation, however, the practitioner may consider
cooling the bile duct via an endoscopic nasobiliary drainage
tube or intraoperatively placed bile duct catheter to prevent
thermal injury to the bile duct.48,49 When biliary injury does
occur, a bile duct stricture is the typical result. When the
stricture affects a peripheral bile duct, it tends to be asymp-
tomatic.30,40 No treatment is necessary in asymptomatic
patients, but percutaneous or endoscopic drainage may be
necessary for more severe cases, particularly if the patient
develops jaundice, cholangitis, or abscess.
Hepatic abscess is one of the most common major com-
plications after percutaneous thermal ablation in the liver
with an overall risk of 0.3 to 2% (►Fig. 3).28,29,31,37,38 Two
important risk factors for abscess formation are recognized:
bacterial colonization of the biliary tract and diabetes melli-
tus. Colonization of the biliary tract may take place through a
bilioenteric anastomosis, endoscopic sphincterotomy, biliary
stent, or pneumobilia of unknown origin.15,40 Although pro-
phylactic use of antibiotics is controversial, many practices
routinely use antibiotics in patients with bilioenteric anasto-
mosis.30,38,40,50 If an abscess does develop following percu-
taneous ablation, it is typically managed similar to abscesses
from other etiologies. Smaller abscess can often be managed
with antibiotic therapy alone, whereas larger abscesses will
require percutaneous drainage.
Extrahepatic Complications
Extrahepatic complications of liver ablation include direct
penetration and thermal injury to adjacent organs, needle
tract seeding, and thermal effect upon remote organs.29,40
Pneumothorax and hemothorax, which are related to the
image-guided placement of needles, are rare but may be
encountered when treating lesions near the dome of the
liver, particularly when a transpleural approach is used
(►Fig. 4).29,30,40 A chest radiograph should be performed
anytime chest pain or dyspnea occurs following an ablation.
In this situation, pneumothorax and hemothorax are usually
self-limited.40 However, if the patient becomes symptomatic
or if there is suspicion for an active air leak, a thoracostomy
tube may be needed. In addition, when treating lesions in the
dome of the liver, the risk of diaphragmatic injury is in-
creased. Although most diaphragmatic injuries are self-limit-
ed, the diaphragmmaybecome thinner andweaker as a result
of the injury. In patients with elevated intra-abdominal
pressure, such as a cirrhotic patient with ascites, the combi-
nation of increased abdominal pressure and a weakened
diaphragm may lead to a diaphragmatic hernia.15,30
Gastrointestinal injury is an uncommon complication of
hepatic thermal ablation, but is particularly important given
Figure 3 (A) Preablation contrast-enhanced MRI demonstrates an area of early enhancement (arrow) in segment IVa that demonstrated washout
and late capsule enhancement (not shown), worrisome for hepatocellular carcinoma in this patient with hepatitis C and cirrhosis. (B) Noncontrast-
enhanced CT acquired 2 weeks after ablation (done noncontrast due to acute renal failure) demonstrates a fluid and gas collection in the ablation
bed (arrow). (C) Image from a more caudal location as B demonstrates a small amount of biliary gas (arrow), suggesting communication of the
abscess cavity with the biliary tree. (D) Noncontrast-enhanced CT of the abdomen following percutaneous drainage of the abscess demonstrates
resolved abscess cavity in the ablation bed with the pigtail drain still visible (white arrow). CT, computed tomography; MRI, magnetic resonance
imaging.
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its severity.29,37,38,51 The colon is considered to be at espe-
cially high risk for perforation due to its relatively thin wall
and fixed position. The stomach and small bowel are thought
to be less heat sensitive because of thick gastric wall and
peristalsis of the small bowel.29,30,40 Adhesions from prior
surgery or chronic cholecystitis also contribute to the risk of
bowel perforation by limiting bowel motility.29,32 The re-
ported incidence of colon perforation is estimated between
0.1 and 0.3%.51 Although the exact safetymargin has not been
defined, a minimum distance of 1 cm between the ablation
zone and bowel wall has been suggested to be sufficient to
prevent bowel injury29,32,51,52Multiple techniques have been
proposed to protect the bowel against thermal damage
during ablation procedures. The least invasive method in-
volves positioning of the patient in the right anterior oblique
position, so as to allow gravity to draw the hepatic flexure of
colon away from the liver surface.51 Should this not work, one
can attempt to displace the bowel loops from the liver
surface51,53; this can be accomplished through hydrodissec-
tion, a technique where 5% dextrose water or carbon dioxide
is injected into the peritoneal cavity between the lesion and
the bowel. The use of ionic solutions, such as saline, should be
avoided with RFA due to the propensity of such solutions to
conduct rather than insulate current. Another method of
displacement involves using a balloon catheter that is placed
between the liver surface and the bowel loops. Either inde-
pendently or in conjunction with the above techniques, one
can place independent thermometers to monitor temper-
atures near critical structures in real time during abla-
tion.28,54 If the temperature becomes significantly elevated,
either the ablation probe can be repositioned or the proce-
dure can be stopped. Management of gastrointestinal tract
injuries includes fasting, antibiotic therapy, and drainage of
any subsequent abscess. Surgerymay be required if the injury
does not heal and results in peritonitis.40
Cholecystitis may occur with thermal ablation of a mass
adjacent to the gallbladder. Althoughminimalwall thickening
is often seen on follow-up imaging, symptomatic cholecystitis
or gallbladder perforation is very rare, because fluid content
in the gallbladder lumen plays a role in dissipation of heat
around the gallbladder fossa.30,40
Tumor seeding from the needle tract is extremely uncom-
mon, with rates reported from 0.3 to 4%
(►Fig. 5).29,30,38,40,42,55–58 There are several factors that
may increase the risk of tumor seeding, including poor tumor
differentiation, subcapsular location, prior percutaneous bi-
opsy, multiple treatment sessions, and placement of multiple
needles.28–30,42,59,60 To avoid needle tract seeding, the num-
ber of punctures and repositioning of the needle should be
minimized, and the needle should be placed in such a way
that traverses sufficient normal hepatic parenchyma. Cauter-
ization of the needle tract may be effective for the prevention
of needle tract seeding, especially in the case of a subcapsular
tumor.29,30,40 Because seeded tumors tend to grow very
slowly, a long follow-up period is necessary to exclude this
complication.40 When it does occur, the treatment will
depend on the exact size and location, but there are reports
of successful management with thermal ablation.58,60
In addition to local thermal injury predicted near the site
of ablation, distant thermal injury is another potential com-
plication.1,28,30,42,61,62 Monopolar radiofrequency electrodes
require grounding pads to complete the high-current radio-
frequency circuit, and the same amount of current is deposit-
ed at the grounding pad as the electrode itself. This puts the
grounding pad sites at risk for thermal injury, and severe
burns have been reported in early studies of RFA. From that
experience, it was realized that to disperse the energy more
effectively, larger grounding pads were necessary. Because
Figure 4 (A) Axial postcontrast T1 MR image in the lower abdomen
demonstrates a heterogeneously early enhancing mass in segment VI
(arrow), suspicious for hepatocellular carcinoma. (B) Lung window
images after repositioning of the ablation electrode (arrowheads) into
the segment VI lesion demonstrate a small pneumothorax (arrow). (C)
Axial CT image following chest tube placement after the pneumo-
thorax enlarged on subsequent images during ablation. CT, computed
tomography; MR, magnetic resonance.
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larger grounding pads have become routine, the incidence of
skin burns has becomemuch lower.28–30 Tominimize the risk
of grounding pad burns, the pads need to be placed in full
contact with the skin, relatively far away from the electrode
and equidistant from it, to allow for more even heat distribu-
tion. Excess hair should be removed from the skin to facilitate
full grounding pad contact.28–30 Although microwave does
not require grounding pads, significant skin burns have been
reported at the skin exit site with the use of noncooled
antennas.32 There is even a report of skin burn with use of
cooled antenna due to prolonged cauterization of the needle
tract when the antenna was withdrawn.1
Side Effects of Hepatic Ablation
Side effects of hepatic thermal ablation include pain, asymp-
tomatic pleural effusions, asymptomatic perihepatic fluid or
hemorrhage,minimal thermal damage to adjacent structures,
loose stool, and postablation syndrome. Postablation syn-
drome refers to a constellation of symptoms that has been
observed following thermal ablations in 32 to 58% of pa-
tients.63–65 It is characterized as a self-limited flu-like illness
with low-grade fever,malaise, nausea, and/or vomiting, and it
is thought to be mediated by an inflammatory response to
necrotic tissue that results from ablation.63 Most of the data
suggest that the occurrence and severity of postablation
syndrome are related to the volume of necrotic tissue created
by the ablation.63–65 Andreano et al63 reported in a study
using MWA that the incidence and symptomatology of post-
ablation syndrome seen with hepatic MWA is similar to that
reported with RFA. These authors also mentioned that post-
ablation pain was best predicted by the volume of ablation,
total ablation time, and increases in serum aminotransferase
levels.63 Although fever is the most commonmanifestation of
postablation syndrome, any fever after 2 weeks should
prompt consideration of an underlying infection.29,30
Kidney
As the incidental detection of small renal masses has in-
creased with the use of cross-sectional imaging for other
indications, nephron-sparing techniques such as open or
laparoscopic partial nephrectomy, RFA, and cryoablation
are increasingly being employed in an attempt to decrease
morbidity and preserve renal function in patients with early-
stage renal cell carcinoma.9,29,66,67 Kidney ablation is quite
different from liver ablation. Adjacent heat- or cold-sensitive
structures are more common with kidney ablation due to
proximity of the bowel and ureter, and the smaller size of the
organ.42 Overall, the rates of major complications with renal
ablation are 2 to 6%.24,25
RFA and cryoablation are the two most commonly used
ablation techniques. Each has unique technical features and
neither is clearly superior to the other.24 There also does not
appear to be a difference in complication rates between the
two technologies. In a large series of 573 procedures, Atwell et
al68 compared the incidence of major complications between
RFA and cryoablation and found no statistical difference (the
incidencewith RFAwas 4.7% andwith cryoablationwas 7.7%).
Figure 5 (A) Axial postcontrast T1 MR image of the abdomen demonstrates an early enhancing lesion in segment VII (arrow) that demonstrated
later washout and capsular enhancement (not shown), compatible with hepatocellular carcinoma. (B) Oblique coronal ultrasound image of the
liver during radiofrequency ablation demonstrates the radiofrequency electrode (arrowheads) placed into the segment VII lesion (arrow and
measurement). (C) Although no CT images were obtained of the radiofrequency electrode in place, the preablation CT scan shows the laterally
placed skin marker sheet (arrow), with the anticipated skin entry site in this region. (The lesion was not visible on this noncontrast CT). (D) Axial
postcontrast T1 MR image of the abdomen acquired 22 months after radiofrequency ablation demonstrates an enhancing mass (arrow) between
the lateral ribs, compatible with ablation tract seeding. CT, computed tomography; MR, magnetic resonance.
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Within this study, nerve and urothelial injury were more
commonly seen in the RFA group, and bleeding and hematu-
ria were more common in cryoablation group. In general,
increased tumor size and central tumor location were associ-
ated with higher complications rates.68
Vascular Complications
Hemorrhage is the most commonly encountered complica-
tion following renal ablation (►Fig. 6). Massive bleeding
requiring blood transfusion is reported to have an incidence
of 1 to 2%.69–71 Unlike RFA, cryoablation does not cauterize or
coagulate vessels; thus, hemorrhage at the ablation zone
immediately after probe removal is a risk of cryoablation.
Therefore, the patients’ coagulation profile should be cor-
rected before and after the procedure.9 In general, conserva-
tivemanagement or blood transfusion alone is enough for the
treatment of bleeding, as it tends to tamponade, but trans-
arterial embolizationmay be required in patients with severe
blood loss or uncorrectable hypotension. In select patients,
some authors advocate prophylactically embolizing larger
and/or more centrally located tumors to decrease the risk
of hemorrhage.68,72
Hematuria following renal ablation occurs infrequently
and is usually self-limited, resolving within 12 to 24 hours.
Hence, a single episode of hematuria is not a clinical problem,
especially if it progressively clears. Nevertheless, in cases of
more significant hematuria, bladder outlet obstruction may
result from clot formation; this is typically treated with
bladder irrigation.9,42,69
Perinephric hematomas may occur during ablation (< 5%).
Hematomas of 1 cm or smaller are common and typically of
no clinical consequence, and even larger perinephric hema-
tomas are generally self-limited.9,42
Renal infarction rarely develops following ablation. A
segmental infarction is not clinically significant in patients
with good baseline renal function but may cause renal
insufficiency in patients with marginal renal function. Renal
infarction may also result from thermal injury to a small
artery adjacent to a renal mass.69,73
Renal Collecting System Complications
Inadvertent injury of the proximal ureter during renal abla-
tion has been associated with formation of a urinoma, ure-
teral obstruction, and chronic stricture (►Fig. 7). The
incidence of ureteral thermal injury is 1 to 2%. A renal mass
in the medial aspect of the lower pole kidney frequently is in
close proximity to the ureter, which can become constricted
from thermal injury.9,69 Similar to other organs, the precise
safe distance from the ureter has not been determined. Still, it
has been suggested that ureteral injury can be avoided when
the ureter is locatedmore than 2 cm from the ablation zone.69
When one is facedwith the potential of ureteral injury during
renal ablation, it is possible to protect the ureter with the use
of intraprocedural retrograde pyeloperfusion. Cantwell et
al74 reported on early experience in using cooled 5% dextrose
water, instilled by means of retrograde pyeloperfusion via a
ureteral stent, during RFA of renal cell carcinomas located
within 1.5 cm of the ureter. No patient developed ureteral
Figure 6 (A) Axial postcontrast T1 MR image of the abdomen
demonstrates a large exophytic enhancing mass (arrow) arising from
the lower pole of the right kidney. There is an area of hypoenhance-
ment with surrounding fat stranding (arrowheads) from a previous
radiofrequency ablation. (B) Axial noncontrast CT during cryoablation
demonstrates three of the six cryoprobes (arrowheads) placed into the
large right inferior pole renal mass (arrow). (C) Postprocedural non-
contrast axial CT scan performed secondary to hypotension demon-
strates a subcapsular renal hematoma (small arrows) that compresses
the renal parenchyma medially (arrowheads). There is also a retro-
peritoneal hemorrhage (large arrow). The patient developed acute
renal failure and required admission to the hospital as well as trans-
fusion. CT, computed tomography; MR, magnetic resonance.
Seminars in Interventional Radiology Vol. 31 No. 2/2014
Complications of Thermal Ablation of Liver and Kidney Kim, Thomas144
T
hi
s 
do
cu
m
en
t w
as
 d
ow
nl
oa
de
d 
fo
r 
pe
rs
on
al
 u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
is
tr
ib
ut
io
n 
is
 s
tr
ic
tly
 p
ro
hi
bi
te
d.
stricture out of 19 procedures. There was residual tumor in
three patients, but these patients’ tumors had complete
ablation after a second RFA session.74 In addition to injury
to the ureter, urinomas may occur from perforation of any
portion of the collecting system. Fortunately, this is an
uncommon complication and most frequently results from
damage to the calyces. An even rarer occurrence is that of an
urinary-cutaneous fistula.29,75
Extrarenal Complications
Bowel perforation may occur after ablation of a renal mass in
the anterior aspect of the kidney due to its close proximity to
bowel (►Fig. 8). A minimum of 5 mm of fat between the
target tumor and adjacent bowel is suggested to ensure
sufficient insulation to protect the bowel from thermal
harm. Physical separation of the target tumor from adjacent
bowel may reduce the risk of this complication. If there is
insufficient fat between the target tumor and adjacent bowel,
adjunctive maneuvers such as strategic lateral decubitus
patient positioning, hydrodissection using 5% dextrosewater,
carbon dioxide injection, or balloon interposition are recom-
mended to separate the kidney from the bowel.9,29 Thermal
injury to the adjacent liver or spleen is not believed to be
significant.42,76
Genitofemoral nerve injury is another recognized risk of
renal ablation. Thermal injury to the nerve, which originates
from the upper part of the lumbar plexus and descends
laterally along the psoas muscle, can cause chronic pain
and paresthesia in the ipsilateral groin. Injury to the psoas
muscle itself can result in isolated hip flexion weakness.
Sequelae of such nerve injuries are usually temporary, resolv-
ing within 6 months in most patients.9,67,68 Atwell et al
reported that nerve injury occurred much more often after
RFA (3.5%) than cryoablation (0.6%).68 This may be explained,
as the nature of the nerve tissue is more sensitive to heat than
cold injury. One of the strategies to prevent this nerve injury
is hydrodissection or carbon dioxide injection into the fat
adjacent to the tumor to displace the ablation zone away from
the psoas muscle. Another strategy is to employ the needle as
a lever to displace the kidney, using the site of skin entry as a
fixed point to torque the needle handle medially, leading to a
lateral displacement of the renal tumor away from the psoas
muscle.68,69,77
Tumor seeding along the needle tract is an extremely rare
complication of percutaneous renal ablation. Only five cases
of tumor seeding along the needle tract from renal ablation
(two RFA and three cryoablation) have been reported.68,78–81
It is important to be aware that a benign inflammatory tract
mass maymimic needle tract seeding after renal ablation. An
inflammatory tract mass appears as a solid geographic lesion
with mild enhancement around the ablation tract on follow-
up CT or MRI.9,69,82
Pneumothorax has a reported incidence of 2% and usually
develops when the renal tumor is in the upper pole kidney in
close proximity to the lung base, where the posterior basal
lung frequently interposes the pathway of the needle.71
Figure 7 (A) Axial contrast-enhanced CT image of the abdomen demonstrates a cystic and solid left inferior pole renal mass (arrow). Of note,
there is a cystic and solid mass arising from the right kidney as well (arrowhead). The left renal mass was selected to be treated first. (B) Axial
noncontrast-enhanced CT image of the abdomen demonstrates two of the seven cryoprobes (arrowheads) placed into the mass. A small gauge
needle (arrow) was also placed to displace the colon by hydrodissection. (C) Axial contrast-enhanced CT of the abdomen 6 months after
cryoablation demonstrates hypoenhancement and moderate to severe hydronephrosis of the left kidney (arrow). (D) Fluoroscopic-saved image
during placement of a nephrostomy tube (arrowheads) demonstrates a tight stricture of the proximal left ureter (arrow). CT, computed
tomography.
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However, pneumothorax may be artificially produced to
protect lung tissue when there is no safe window due to
the intervening lung base.83 Mild asymptomatic pneumo-
thoraces can usually bemanaged conservativelywith bed rest
and oxygen; however, moderate to severe pneumothorax
typically requires percutaneous drainage.69
Summary
RFA and MWA are widely accepted minimally invasive treat-
ment modalities used in the treatment of liver tumors. In
addition, RFA and cryoablation are two most commonly used
ablation modalities in the treatment of small renal tumors.
Each modality has unique technical features, and in general
the expected complications are similar but not identical.
Therefore, a thorough understanding of each modalities
characteristic profile and complications is essential to maxi-
mize safety when performing the procedures as well as
managing encountered complications properly.
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